Table 1. Representative mouse models of AD.
Tg Line | Gene/Isoform | Mutation | Promoter | Plaques (mo) | Cognitive deficits (mo) | Vendor Number | Reference | |
---|---|---|---|---|---|---|---|---|
hAPP models | ||||||||
PDAPP | hAPP695<751,7701 | Ind | PDGF-B | 6–9 | 6 | n.a. | [27, 41, 49, 73, 110] | |
J20 | hAPP695<751,7701 | Swe, Ind | PDGF-B | 6 | 4 | JAX 006293 | [114, 126] | |
Tg2576 | hAPP695 | Swe | HamPrP | 9 | 10 | Taconic 1349 | [5, 163, 177] | |
APP23 | hAPP751 | Swe | Thy1 | 6 CAA: 12 |
3 | n.a. | [21, 91] | |
TgCRND8 | hAPP695 | Swe, Ind | HamPrP | 3 CAA: 11 |
3 | n.a. | [29, 79] | |
TASD-41 | hAPP751 | Swe, Lon | Thy1 | 3 CAA: 7 |
6 | n.a. | [140] | |
R1.40 | hAPP YAC2 | Swe | hAPP | 14–15 | 16–17 | JAX 005300 | [66, 93, 94] | |
Aβ Models | ||||||||
BRI-Aβ42A | BRI-Aβ42 | n.a. | MoPrP | 3 | ? | JAX 007182 | [106] | |
hAPP/PS1 models | ||||||||
PSAPP (Tg2576 × PS1) | hAPP695 PSEN1 |
Swe M146L |
HamPrP PDGF-B |
6 | 4 | n.a. | [4, 40, 67] | |
APPswe/PS1ΔE9 | m/hAPP6953 PSEN1 |
Swe ΔE9 |
MoPrP MoPrP |
6 | 6 | JAX 004462 | [82, 83, 146] | |
5XFAD | hAPP695 PSEN1 |
Swe, Lon, Flo M146L, L28V |
Thy1 Thy1 |
2 | 6 | JAX 008730 | [89, 118, 122, 123] | |
2xKI | m/hAPP3 PSEN1 |
Swe P264L |
mAPP mPS1 |
6 | 9–12 | n.a. | [25, 184] | |
Models with hTau | ||||||||
TAPP (Tg2576 × JNPL3) | hAPP695 hTau-4R0N |
Swe P301L |
HamPrP MoPrP |
8–15 | motor deficits | Taconic 2469 | [100] | |
3xTg | hAPP695 hTau-4R0N PSEN1 |
Swe P301L M146V |
Thy1 Thy1 mPS1 |
6 | 4.5 | JAX 004807 | [12, 120, 121] | |
htau | hTau PAC4 | Wild-type | hTau | – | 12 | JAX 005491 | [3, 44, 128] |
APP minigene expressing all three isoforms, mostly KPI-positive APPs.
Yeast artificial chromosome, expressing entire human APP gene, including all isoforms.
Humanized mouse APP, in which three amino acids in Aβ are changed to the human sequence.
P1 artificial chromosome, expressing entire human tau gene, including all isoforms (H1 haplotype).